InvestorsHub Logo
Followers 272
Posts 53320
Boards Moderated 3
Alias Born 08/16/2008

Re: None

Sunday, 08/20/2023 8:39:21 PM

Sunday, August 20, 2023 8:39:21 PM

Post# of 398227
OK, I don't like this at all. I've been in stocks a long time and this is, "tricky money" in my strong opinion. He's OUT!
Go BS somewhere else.

Vivek co-founded the technology company Campus Venture Network – offering software and networking resources to college entrepreneurs – in 2007. Ramaswamy also did a stint with the QVT Financial investment advisor from 2007 to 2014. According to his bio, at age 28, he was made partner at the hedge fund, investing in pharmaceutical companies, as per Forbes. Vivek Ramaswamy founded Roivant Sciences, a pharma firm whose goal was “developing and delivering medicines to patients faster and more efficiently,” in 2014, serving as the CEO until 2021. In 2015, Vivek’s image was splashed across the cover of Forbes magazine after he was reported as raising over $350 million for a subsidiary of Roivant, Axovant Sciences. It was an attempt to prop up a failed medication for Alzheimer’s. The same drug again failed tests at Axovant in 2017. Since then, Ramaswamy has co-founded Chapter, a Medicare advisory firm, while also becoming co-founder and executive chairman of Ohio-based company Strive Asset Management.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.